Chugai Pharmaceutical Co., Ltd.
4519
Rangering i aksjer
#356
Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company,... Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company, operating subsidiaries involved in the full lifecycle of drug development, from research and manufacturing to sales, import, and export, serving both Japanese and international markets. Its commercialized product portfolio spans several key therapeutic areas. These include a robust oncology offering with leading treatments like Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda. Additionally, it provides medications for bone health (e.g., Actemra, Edirol, Bonviva), renal conditions (such as Mircera and Oxarol), and neurological or other diverse ailments (including Hemlibra, CellCept, and Enspryng). Beyond its existing offerings, the company maintains an active research and development pipeline. This pipeline features multiple promising candidates targeting oncology, orthopedic and joint disorders, autoimmune diseases, kidney-related conditions, and various neurological or other health issues. Strategic partnerships are central to Chugai's operations, most notably a significant alliance with the Roche Group. The company also fosters collaborative research initiatives with academic institutions. Established in 1925, Chugai's headquarters are located in Tokyo, Japan, and it operates as a key subsidiary of Roche Holding Ltd.
Aksjekurs
$41.32
Markedsverdi
$67.99B
Endring (1 dag)
-0.31%
Endring (1 år)
-14.96%
Land
JP
Handel Chugai Pharmaceutical Co., Ltd. (4519)
Kategori
Healthcare
Markedsverdi av Chugai Pharmaceutical Co., Ltd.(4519)
Markedsverdi: $67.99B
Per October 2026 har Chugai Pharmaceutical Co., Ltd. en markedsverdi på $67.99B. Dette gjør Chugai Pharmaceutical Co., Ltd. til det 356th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Chugai Pharmaceutical Co., Ltd. fra 2000 til 2026
4519 sammenlignet med topp 5 mest populære stocks
